Teladoc Health Q4 revenue $640.5M (-3% YoY); full-year net loss $1.0B on $790M goodwill impairment

Teladoc Health, Inc.

2024-FY EPS reported -$5.87 revenue$2,569,574,000

Q4 revenue $640.5M (-3% YoY); full-year revenue $2,569.6M (-1% YoY).
Q4 net loss $48.4M ($0.28/share); full-year net loss $1,001.2M ($5.87/share) includes $790M non-cash goodwill impairment in BetterHelp.
Q4 adjusted EBITDA $74.8M (-35% YoY); full-year adjusted EBITDA $310.7M (-5% YoY).
Integrated Care segment revenue +2% in Q4; BetterHelp segment revenue -10% in Q4, segment weakness persists.
2025 guidance: revenue $2,468-2,576M, adj. EBITDA $278-319M, net loss per share ($1.10)-($0.50); includes Catapult Health acquisition expected close Feb 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.